General

High Cholesterol Linked With Christmas Meal: Study

Author : NewsGram Desk

While we all love to binge on rich, palatable Christmas meals, its consumption in large quantities may boost cholesterol levels, researchers have warned.

The study showed that right after the Christmas break, butter and cream in Christmas foods boost cholesterol levels more than assumed and that levels are 20 per cent higher than in the summers (May to June).

"Our study shows strong indications that cholesterol levels are influenced by the fatty food we consume when celebrating Christmas. The fact that so many people have high cholesterol readings straight after the Christmas holiday is very surprising," said Anne Langsted, from the University of Copenhagen in Denmark.

For the study, the researchers included 25,764 individuals.

Findings, published in the journal Atherosclerosis, showed that the risk of having elevated cholesterol is six times higher after the Christmas break.

People who already have high cholesterol should perhaps be even more alert during the Christmas holidays, the team suggested.

Christmas is celebrated every year to celebrate the birth of Jesus Christ

"For individuals, this could mean that if their cholesterol readings are high straight after Christmas, they should consider having another test taken later on in the year," said Signe Vedel-Krogh, researcher from the varsity.

Excess cholesterol in the blood is linked to a greater risk of developing heart attacks and stroke which is a leading cause of death worldwide, the study noted. (IANS)

Subscribe to our channels on YouTube and WhatsApp 

12 Top Maoist Leaders Surrender Today in Chhattisgarh; Major Breakthrough in Anti-Naxal Drive

Parliament Winter Session 2025: Live Updates Day 6 - 'Vande Mataram' Discussion Continues in Lok Sabha

“150 Glorious Years of Vande Mataram”- Debate in Lok Sabha Today; Why Jawaharlal Nehru Chose 'Jana Gana Mana' as The National Anthem over 'Vande Mataram'

AI-Based Diagnostic Tools Boosting TB, Diabetes Care: Govt

Biocon to Fully Integrate Biologics Unit in $5.5 Billion Deal